The downgrade from Buy to Neutral by a major financial institution like Goldman Sachs indicates a less optimistic outlook for the company's stock. This could potentially lead to a decrease in the stock's price in the short term. The new price target of $22 also suggests that the analyst believes the stock is currently overvalued.